There are 2789 resources available
1808P - MET fusions as therapeutic targets in solid tumors
Presenter: Sabrina Borchert
Session: ePoster Display
1809P - Evaluation of KRAS mutation subtype on survival in patients with metastatic non-small cell lung cancer receiving immunotherapy
Presenter: Carly Barron
Session: ePoster Display
1810P - Tumor metabolite lactate promotes tumorigenesis through modulating Moesin lactylation and TGF-b signaling of regulatory T cells
Presenter: Jian Gu
Session: ePoster Display
Resources:
Abstract
1811P - Molecular characterization of epidermal growth factor receptor-mutated (EGFR-m) non-small cell lung cancer (NSCLC) undergoing histological transformation
Presenter: Laura Bonanno
Session: ePoster Display
1812P - Clinical and pathological features and prognosis of non-small cell lung cancer (NSCLC) patients with adenocarcinomas without TTF1 and Napsin A expression
Presenter: Franziska Kraus
Session: ePoster Display
1850P - Communication patterns and cascade testing among pathogenic variant carriers
Presenter: Dione Aguilar
Session: ePoster Display
1851P - Introduction of a G8 screening programme for older cancer patients
Presenter: Michelle Hannan
Session: ePoster Display
1853P - The estimated cancer risks associated with being a carrier for an ATM gene mutation among UK Biobank population
Presenter: Pimkhuan Kamnerdsupaphon
Session: ePoster Display
1854P - Multicentric, comparative, retrospective study on the safety and efficacy of conventional chemotherapy in cirrhotic patients with gastrointestinal cancer
Presenter: Massih Ningarhari
Session: ePoster Display
1855P - Logistic and documentary factors influencing reasonable tumorboard decisions
Presenter: Lars Galonska
Session: ePoster Display